 Postoperative active specific immunization colorectal cancer patients virus-modified autologous tumor-cell vaccine First clinical results tumor-cell vaccines live avirulent Newcastle disease virus erratum Cancer Apr Sixteen patients colorectal carcinoma Dukes Stage autologous virus-modified tumor-cell vaccine potential curative tumor resection inoculum cells hemagglutination units nonirradiated Newcastle disease virus NDV times intervals delayed-type hypersensitivity DTH reaction vaccination patients reactivity vaccine vaccination procedure challenge test autologous tumor cells NDV vaccination cycle specific antitumor sensibilization patients DTH response due bacterial contamination sensibility virus Histologic examination vaccination site dense infiltration T-lymphocytes patients active specific immunization specific antitumor sensitivity